Seattle Genetics | Deudores Comerciales



Trade Debtors Cambio Fecha
AbbVie USD 10.92B 553M 2024-12
Acadia Pharmaceuticals USD 113.71M 9.02M 2025-03
Agios Pharmaceuticals USD 3.34M 765K 2025-03
Amgen USD 8.13B 1.35B 2025-03
Astellas Pharma JPY 646.22B 11.38B 2025-03
Bayer EUR 16.74B 4.24B 2025-03
Biogen USD 2B 127.7M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Celldex Therapeutics USD 1.06M 364K 2025-03
Daiichi Sankyo JPY 619.1B 5.07B 2025-03
Eisai JPY 220.02B 15.62B 2025-03
Eli Lilly USD 14B 727.8M 2025-03
Exelixis USD 281.64M 16.2M 2025-04
Genmab DKK 799M 5.89B 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Glaxosmithkline GBP 7.32B 542M 2024-12
Incyte USD 823.13M 30.02M 2025-03
Insmed USD 47.75M 4.27M 2025-03
MacroGenics USD 4.31M 4.44M 2024-12
Merck USD 11.57B 452M 2025-03
Moderna USD 306M 286M 2025-03
Novartis USD 9B 854M 2024-12
Pfizer USD 14.74B 32M 2025-03
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Sanofi 447M 10.18B 2025-03
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Takeda JPY 725.25B 9.81B 2025-03
Teva Pharmaceutical Industries USD 3.38B 325M 2025-03
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12
Xencor USD 37.78M 23.06M 2025-03



Seattle Genetics Deudores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.